Hirotsugu Ariizumi

Plasma Levels of Soluble PD-L1 Correlate With Tumor Regression in Patients With Lung and Gastric Cancer Treated With Immune Checkpoint Inhibitors

Kiyohiro Ando, Kazuyuki Hamada, Makoto Watanabe et al. · Anticancer Research · 2019 · 62 citations · Full text

Medicine, Oncology, Pharmacology +17

Turicibacter and Acidaminococcus predict immune-related adverse events and efficacy of immune checkpoint inhibitor

Kazuyuki Hamada, Junya Isobe, Kouya Hattori et al. · Frontiers in Immunology · 2023 · 48 citations · Full text

Life Sciences, Microbiology, Oncology +16

Antibiotic Usage Reduced Overall Survival by over 70% in Non-small Cell Lung Cancer Patients on Anti-PD-1 Immunotherapy

Kazuyuki Hamada, Kiyoshi Yoshimura, Yuya Hirasawa et al. · Anticancer Research · 2021 · 44 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Status of Natural Killer Cell Recovery in Day 21 Bone Marrow after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Clinical Outcome

Norimichi Hattori, Bungo Saito, Yohei Sasaki et al. · Biology of Blood and Marrow Transplantation · 2018 · 37 citations · Full text

Life Sciences, Hematology, Immunology +17

Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody

Masakazu Murayama, Masahiro Hosonuma, Atsuo Kuramasu et al. · Scientific Reports · 2024 · 36 citations · Full text

Medicine, Immunology, Oncology +17